These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6420990)

  • 1. [Clinico-morphological characteristics and results of treatment of endometrioid cystadenocarcinoma of the ovary].
    Vinokurov VL; Livshits MA; Tsyrlina EV; Kolosov AE
    Vopr Onkol; 1983; 29(12):49-56. PubMed ID: 6420990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advanced cancer of the ovary. Treatment and results].
    Wolff JP; George M; Duvillard P; Michel G; Pejovic MH; Haie C
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):231-7. PubMed ID: 3722750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the dissemination process in patients with serous cystadenocarcinoma of the ovaries].
    Dzhilavian GA
    Vopr Onkol; 1984; 30(8):83-6. PubMed ID: 6485289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognosis of ovarian cancer depends on the CA125 value at the end of induction therapy].
    Miwa K; Dozono H; Iemura K; Shinmura R; Nakamura Y; Matsumoto T; Ikeda S; Nagata Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):557-61. PubMed ID: 2056230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of treatment of primary ovarian carcinoma.
    Saarikoski S; Selander K; Kauppila O; Raitala R; Pystynen P
    Ann Chir Gynaecol; 1982; 71(3):156-60. PubMed ID: 7114781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analytical studies on the treatment of adenocarcinoma of the ovary].
    Matsumoto Y; Kasamatsu T; Sonoda T; Ohmi K; Tsunematsu R; Tanemura K; Yamada T; Kishi K
    Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):778-88. PubMed ID: 6491429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical situation and therapy of ovarian carcinoma at Gynaecological Hospital of Jena University, between 1967 and 1976 (author's transl)].
    Meinhold P; Sommer H; Nöschel H; Günther M
    Zentralbl Gynakol; 1981; 103(21):1280-8. PubMed ID: 7324630
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of ovarian carcinoma--a review of 420 cases.
    Barr W; Cowell AC; Chatfield WR
    Scott Med J; 1970 Jul; 15(7):250-6. PubMed ID: 5427786
    [No Abstract]   [Full Text] [Related]  

  • 9. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
    Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H
    Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and survival of patients with serous cystadenocarcinoma of the ovaries.
    Demopoulos RI; Bigelow B; Blaustein A; Chait J; Gutman E; Dubin N
    Obstet Gynecol; 1984 Oct; 64(4):557-63. PubMed ID: 6483302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued controversies in the diagnosis and treatment of ovarian adenocarcinomas.
    Piver MS
    J Reprod Med; 1979 Mar; 22(3):119-27. PubMed ID: 108399
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
    Dzhilavian GA; Vinokurov VL
    Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical course of benign epithelial ovarian tumors].
    Mitrokhina MV
    Vopr Onkol; 1980; 26(3):78-81. PubMed ID: 7368661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the role of chemotherapy adjuvant to surgery in patients with cancer of the ovary, 1st stage].
    Nechaeva ID; Vinokurov VL; Nikolaeva DV; Livshits ME; Aĭnbinder NM
    Vopr Onkol; 1983; 29(3):46-53. PubMed ID: 6836987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of patients with marginal tumors of the ovary].
    Vinokurov VL
    Vopr Onkol; 1989; 35(7):870-4. PubMed ID: 2773407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of serous adenocarcinoma of the ovary by a protocol consisting of 1st surgery, polychemotherapy with cisplatin as base, surgical reoperation for control, and radiotherapy and/or maintenance chemotherapy. Study of a series of 56 cases. Thoughts and prospects].
    Clavel B; Delouche G; Harvey P; Berlie J; Laval C; Tubiana-Hulin M; Lemoine F
    Ann Chir; 1984 Jun; 38(5):337-47. PubMed ID: 6541016
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival of patients with malignant tumors of the ovaries in relation to the stage according to the TNM classification].
    Kotova DG
    Vopr Onkol; 1976; 22(1):36-43. PubMed ID: 1266119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary.
    Norris HJ
    Int J Gynecol Pathol; 1993 Apr; 12(2):134-40. PubMed ID: 8463037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.